Global Frusemide Market, By Route of Administration (Oral, Intravenous and Others), End User (Hospitals, Specialty Clinics and Home Healthcare), Mode of Purchase (Prescription and Over the Counter), Distribution Channel (Veterinary Clinics, Veterinary Pharmacies, Online Veterinary Stores and Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Frusemide Market
Global furosemide market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a healthy CAGR of 4.20% in the above-mentioned research forecast period.
Furosemide is a diuretic pill, which is potent and its main role is to eradicate water and salt from the body. Salt, water and other molecules are filtered from the blood and into the tubules of the kidney. The mode of action of Furosemide is blockage of the absorption of sodium, chloride and water, from the filtered fluid into the kidney tubules, which results in the increase of urine output (diuresis). Furosemide is used either alone or combined with other medications to cure high blood pressure. To remove excess fluid within the tissues, to treat heart, kidney and liver problems, furosemide is used. Lasix is a trade name for furosemide, is a diuretic agent which is prescribed for retaining the fluid balance in patients suffering from congestive heart failure, liver disease.
The rise in number of patients suffering from chronic kidney disorders and the rise in geriatric population and the availability of medical remuneration health insurance and increased awareness about the use of furosemide medication and increased preference for intravenous medication are the factors which will drive the market growth. According to the data shared by the National Kidney Foundation, around 37 million people are affected due to chronic kidney diseases.
However, the presence of stringent regulations by FDA for the drug approval and increased medical expenses and lack of patient awareness and increased count in product recalls are the restraints which can hamper the market growth. The presence of untapped opportunities in Asia Pacific and the increase in number of upcoming healthcare infrastructure and rise in initiatives by market players and technological developments for furosemide medication are the opportunities which are expected to boost the market growth.
For instance, the partnership between Ligand Pharmaceuticals Incorporated and the SQ Innovation AG explains the use of Ligand's Captisol technology in the formulation of furosemide at a high concentration, for the treatment of edema in patients with heart failure. The challenges which are likely to tamper the market growth are the use of alternatives and the accessibility of off-label drug usage.
This frusemide market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Frusemide Market Scope and Market Size
The frusemide market is segmented on the basis of route of administration, end user, mode of purchase and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of route of administration, the frusemide market is segmented into oral, intravenous and others.
- On the basis of end user, the frusemide market is segmented into hospitals, specialty clinics and home healthcare.
- On the basis of mode of purchase, the frusemide market is segmented into prescription and over the counter.
- On the basis of distribution channel, the frusemide market has also been segmented into hospital pharmacies, retail pharmacies and online pharmacies.
Frusemide Market Country Level Analysis
Frusemide market is analyzed and market size information is provided by country, route of administration, end user, mode of purchase and distribution channel as referenced above.
The countries covered in the frusemide market report are U.S., Canada, Mexico in North America, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America is expected to hold the largest market share due to the increased count in number of specialty clinics and increased necessity for furosemide in research and healthcare institutes and ease of availability. Asia-Pacific is expected to account for the fastest growing market due to rise in awareness about management of the chronic diseases and rise in number of ambulatory surgical center in the region and awareness through workshops.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Frusemide market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Frusemide Market Share Analysis
Frusemide market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to frusemide market.
The major players covered in the frusemide market are Sanofi, Pfizer Inc, Mylan NV, Emcure Pharmaceuticals, Sun Pharmaceuticals Industries Ltd, Sterimax Inc, Sandoz AG, Novartis AG, Bayer AG, Aurobindo Pharma, Amneal Pharmaceuticals LLC, Ipca Laboratories Ltd, WOCKHARDT, among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-